Therapy for idiopathic precocious puberty in children

被引：1

作者：

Shim, Kye Shik ^{[1
]}

Kim, Jung Tae ^{[2
]}

机构：

[1] Kyung Hee Univ, Sch Med, Dept Pediat, Seoul, South Korea

[2] Kyung Hee Univ, Sch Pharm, Kyung Hee Univ Hosp Gangdong, Dept Pharm, Seoul, South Korea

来源：

JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | 2011年 / 54卷 / 09期

关键词：

Precocious puberty; Gonadotropin-releasing hormone; Agonist;

D O I：

10.5124/jkma.2011.54.9.953

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The incidence of idiopathic precocious puberty is rapidly increasing in Korea. The most common medication used for treatment is a gonadotropin releasing hormone agonist. However, there is some debate regarding the indication and timing of treatment, and the dosage of the medication, because there are many factors that can affect growth in children after delaying puberty. Also, there are new medications that can potentially delay the puberty with children, for example, gonadotropin releasing hormone antagonists and aromatase inhibitors which require extensive further study.

引用

页码：953 / 956

页数：4